[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:tenosynovial-giant-cell-tumor":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":27,"states":28},"Tenosynovial Giant Cell Tumor",3,[7,15,21],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT04192344","A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor",[11],"Phase 1","RECRUITING","2026-08-26T02:19:13.549512Z","2026-05-05T02:43:28.300274Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT07075471","MOVE: Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib",[],"2026-08-26T02:18:17.007929Z","2026-07-30T01:46:14.467489Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT04635111","A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment",[],"2026-08-26T02:15:13.282904Z","2026-05-13T02:55:06.257085Z",[],[]]